In particular, he is interested in molecular imaging for the characterization of primary advanced techniques such as PSMA targeted PET/CT and PET/MRI and multiparametric prostate MRI, including sodium imaging with correlation to co-registered histopathology.  The use of PSMA PET for the detection and treatment of primary and oliogometastatic prostate cancer with precision radiotherapy is another of area of research interest.

Bauman is also a Professor and past Chair/Chief (2005-2020) of the Department of Oncology at the Schulich School of Medicine and Dentistry, Western University in London, Ontario and is an Associate Scientist, Lawson Health Research Institute.  Bauman received both his undergraduate and medical degrees from the Western University, where he also completed his residency in radiation oncology. He completed a clinical fellowship in radiation oncology in the area of adult and pediatric brain tumour treatment at the University of California at San Francisco.